Hydroxychloroquine for Post-exposure Prophylaxis to Prevent Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Trial – Slides

Oral presentation by Ruanne V. Barnabas at the Delivery of Telehealth in Clinical Care and Research Interventions: Challenges, Barriers, Success, and Future Considerations conference on June 2021. The presentation describes a multi-site, double-blind, controlled, house-hold level randomized trial of Hydroxychloroquine for Post-exposure Prophylaxis to prevent SARS-CoV-2 acquisition. Recruitment for this study was done through health systems, social media recruitment focused on high incidence areas, website sign-up, eConsent, telehealth, self collection, courier/mail transport.

New Hope Against AIDS in CA – Factsheet

This factsheet, entitled New Hope Against AIDS in California explains three interventions including Treatment as Prevention (TasP), Post-Exposure Prophylaxis (PEP), and Pre-Exposure Prophylaxis (PrEP) and how Californians living with and at-risk of HIV infection will be able to access them, with expanded insurance access now available under the Affordable Care Act (ACA).